HIT vs DIC: why one clots and the other bleeds, and how nursing care differs

The deciding question: heparin exposure or a major trigger?

HIT has one cause: heparin. MSD Manuals reports it in up to 2.4 percent of clients on unfractionated heparin, and it can follow tiny exposures such as line flushes. The Pharmaceutical Journal places the typical platelet fall between days 5 and 10 of treatment, sooner in someone who received heparin recently.

DIC always rides on another illness. MSD Manuals lists obstetric complications such as placental abruption, gram-negative sepsis, some cancers, major trauma and shock. A client with DIC is already sick from something else, while a client with HIT may be a stable postoperative patient whose only new problem is the platelet count.

Why HIT clots and DIC bleeds

In HIT, antibodies activate platelets so they clump and block vessels. MSD Manuals describes paradoxical arterial and venous clots, including limb artery occlusion, stroke and heart attack, and states that bleeding rarely occurs. A cold, pale leg or new chest pain in a client on heparin fits HIT better than oozing does.

DIC uses up platelets and clotting factors faster than the body replaces them. MSD Manuals notes it can cause both clots and bleeding, with rapid-onset DIC mainly bleeding. So which condition causes bleeding and clotting together? DIC is the classic answer, though its slow form can present mostly with clots.

Labs that separate them

Both lower the platelet count, so platelets alone cannot settle it. In HIT, the warning sign is a drop of more than 50 percent from baseline, while the clotting times are not the point. In rapidly evolving DIC, MSD Manuals lists severe thrombocytopenia, prolonged PT and aPTT, falling fibrinogen and raised D-dimer.

HIT is confirmed with antibody testing against heparin bound to platelet factor 4, often guided by a 4Ts probability score. The nurse does not wait for that result to act when the provider suspects HIT, because heparin is stopped on suspicion.

Opposite rules for heparin and platelets

Should heparin be stopped in HIT? Yes, all of it. The Pharmaceutical Journal specifies stopping heparin locks and flushes too, then starting a non-heparin anticoagulant such as argatroban or bivalirudin. Low molecular weight heparin is not a safe swap because most HIT antibodies cross-react with it, and warfarin is held until platelets recover.

Platelet transfusion is the other reversal. In HIT, prophylactic platelets are not recommended because they may feed more clotting. In DIC with serious bleeding, MSD Manuals describes replacing platelets, cryoprecipitate for fibrinogen and fresh frozen plasma while the underlying cause is treated.

Hypothetical practice scenario

Hypothetical scenario, not a real exam item: a client on day 7 of subcutaneous heparin after hip surgery has a platelet count that fell from 240,000 to 95,000 and a cool, mottled left foot. The provider stops the heparin. Which order should the nurse question: start argatroban, flush the IV with heparin, or obtain an HIT antibody test?

The heparin flush. It looks routine, which is exactly why it slips through, yet even flush amounts keep the reaction going. Argatroban fits as a non-heparin anticoagulant, and the antibody test confirms the diagnosis. The cool foot suggests arterial clotting and needs prompt reporting.

Sources and further reading

MSD Manual Professional Version: Thrombocytopenia, Other Causes. HIT incidence, flush-level exposure, greater than 50 percent drop, arterial and venous thrombosis, bleeding rare, stop heparin, non-heparin anticoagulants, LMWH cross-reactivity, warfarin delay, 4Ts score.

The Pharmaceutical Journal: Heparin-induced thrombocytopenia. Onset days 5 to 10 and faster with prior exposure, stopping heparin locks and flushes, avoiding prophylactic platelet transfusion.

MSD Manual Professional Version: Disseminated Intravascular Coagulation. DIC causes, bleeding and clotting, lab pattern, treatment of cause and replacement with platelets, cryoprecipitate and plasma.